Pelin G. Ersan - Publications

Assessing the significance of CCNE1 overexpression in triple negative breast cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 28, 2026

Why emerging leaders should focus on being good postdoctoral supervisors.

Journal: FEBS letters

Published: September 01, 2025

Polyol pathway-generated fructose is indispensable for growth and survival of non-small cell lung cancer.

Journal: Cell death and differentiation

Published: April 25, 2024

Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer.

Journal: bioRxiv : the preprint server for biology

Published: March 18, 2024

Targeting LINC00152 activates cAMP/Ca2+/ferroptosis axis and overcomes tamoxifen resistance in ER+ breast cancer.

Journal: Cell death & disease

Published: November 21, 2023

Toxic PARP trapping upon cAMP-induced DNA damage reinstates the efficacy of endocrine therapy and CDK4/6 inhibitors in treatment-refractory ER+ breast cancer.

Journal: Nature communications

Published: February 28, 2023

Targeting HIF1-alpha/miR-326/ITGA5 axis potentiates chemotherapy response in triple-negative breast cancer.

Journal: Breast cancer research and treatment

Published: December 06, 2021

TLR ligand loaded exosome mediated immunotherapy of established mammary Tumor in mice.

Journal: Immunology letters

Published: March 14, 2021

Targeting Adenosine with Adenosine Deaminase 2 to Inhibit Growth of Solid Tumors.

Journal: Cancer research

Published: January 31, 2021

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.

Journal: Nature communications

Published: August 19, 2019

Systems-level Analysis Reveals Multiple Modulators of Epithelial-mesenchymal Transition and Identifies DNAJB4 and CD81 as Novel Metastasis Inducers in Breast Cancer.

Journal: Molecular & cellular proteomics : MCP

Published: March 15, 2019

Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers.

Journal: Cell death and differentiation

Published: June 19, 2018